SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-156663
Filing Date
2023-05-30
Accepted
2023-05-30 16:48:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d463802d424b3.htm 424B3 87415
2 GRAPHIC g463802g02p03.jpg GRAPHIC 66115
  Complete submission text file 0001193125-23-156663.txt   179694
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-272064 | Film No.: 23977241
SIC: 2836 Biological Products, (No Diagnostic Substances)